Can Modulating Inflammatory Response be a Good Strategy to Treat Neuropathic Pain?

Publisher： Bentham Science Publishers

E-ISSN： 1873-4286|21|7|831-839

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.21, Iss.7, 2015-02, pp. : 831-839

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Can targeting SIRT-1 to treat type 2 diabetes be a good strategy? A review

By Pulla Venkat Koushik   Battu Madhu Babu   Alvala Mallika   Sriram Dharmarajan   Yogeeswari Perumal  

Expert Opinion on Therapeutic Targets, Vol. 16, Iss. 8, 2012-08 ,pp. : 819-832

Informa Healthcare

Access to resources Recommend Favorite

Targeting cannabinoid agonists for inflammatory and neuropathic pain

By Cheng Yuan   Hitchcock Stephen A  

Expert Opinion on Investigational Drugs, Vol. 16, Iss. 7, 2007-07 ,pp. : 951-965

Informa Healthcare

Access to resources Recommend Favorite

Neuropeptides in neuropathic and inflammatory pain with special emphasis on cholecystokinin and galanin

By Wiesenfeld-Hallin Z.   Xu X.-J.  

European Journal of Pharmacology, Vol. 429, Iss. 1, 2001-10 ,pp. : 49-59

Elsevier

Access to resources Recommend Favorite

Spinal analgesic action of endomorphins in acute, inflammatory and neuropathic pain in rats

By Przewlocka B.   Mika J.   Labuz D.   Toth G.   Przewlocki R.  

European Journal of Pharmacology, Vol. 367, Iss. 2, 1999-02 ,pp. : 189-196

Elsevier

Access to resources Recommend Favorite

Fluoxetine, a selective serotonin reuptake inhibitor modulates inflammatory and neuropathic pain in the rat

By Pal Singh Vijay   Jain Naveen K.   Kulkarni S. K.  

Inflammopharmacology, Vol. 9, Iss. 3, 2001-06 ,pp. : 219-228

VSP

Access to resources Recommend Favorite